No abstract available
Keywords:
Guillain-Barré syndrome (GBS); Immune-related adverse events; Immunotherapy; Lung cancer; Tumor immune microenvironment.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma of Lung / drug therapy*
-
Adenocarcinoma of Lung / pathology
-
Aged, 80 and over
-
Antineoplastic Agents, Immunological / adverse effects*
-
Guillain-Barre Syndrome / chemically induced
-
Guillain-Barre Syndrome / immunology
-
Guillain-Barre Syndrome / pathology*
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / pathology
-
Male
-
Nivolumab / adverse effects*
-
Tumor Microenvironment / immunology*
Substances
-
Antineoplastic Agents, Immunological
-
Nivolumab